Alicia Alford, a recent graduate of the BULLS Life Sciences Academy and Durham Technical Community College, said Accelerate ...

Kansas lawmakers approved $80 million in bonds for a new KBI headquarters in downtown Topeka. The KBI director expressed gratitude for the funding, though it is less than the original request.

NEWTOWN SQUARE, Pa., May 12, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of ...

Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.25 per share a year ago. These ...

TORONTO - Quantum BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company with a market capitalization of $30.1 million, has announced the purchase of an additional $1 million in Bitcoin and ...

Quantum Biopharma has purchased an additional $1 million worth of Bitcoin and other cryptocurrencies, the Canadian biotechnology company said. The buys take Quantum’s total cryptocurrency ...

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”) a ...

GT Biopharma completed dosing in Cohort 1 and began Cohort 2 of its Phase 1 trial for GTB-3650 with no safety concerns. Early data shows increased NK cell activity, indicating promising immune ...

(RTTNews) - Quantum BioPharma Ltd. (QNTM) has expanded its cryptocurrency portfolio with an additional $1 million investment in Bitcoin or BTC and other digital assets, following board approval.